Skip to main content
Clinical Trials/NCT01348334
NCT01348334
Completed
Not Applicable

Use Of Three Types Of Synthetic Mesh Materials In Sling Surgery: A Prospective Randomized Clinical Trial Evaluating Effectiveness And Complications

Ataturk Training and Research Hospital0 sites144 target enrollmentJuly 2004
ConditionsIncontinence

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Incontinence
Sponsor
Ataturk Training and Research Hospital
Enrollment
144
Primary Endpoint
continence rates at three years after surgery
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to determine the clinical results contributions to surgical success,and complications of mixed type of mesh materials as well as prolen mesh materials in sling surgery in a 3 year follow-up the first time in literature.

Detailed Description

Broad based double forced sling operations were performed in 144 patients by using 3 different types of mesh materials between 2004 and 2007. Group I consisted of 48 patients in whom Vypromesh® (Ethicon,USA) was used; Group II consisted of 48 patients in whom Ultrapromesh®( Ethicon,USA) and Group III consisted of 48 patients in whom Prolene light mesh® (Johnson\&Johnson,USA) was used. The data of the patients and the success of the operation were evaluated based on 24hr pad test, ICIQ-SF scoring, and Korman questionnaire analysis. Main outcome measures:The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.

Registry
clinicaltrials.gov
Start Date
July 2004
End Date
November 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Ataturk Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Stress urinary incontinence
  • Mix urinary incontinence
  • Previous failed anti-incontinence surgery
  • Previous gynecologic surgery

Exclusion Criteria

  • Urodynamical detrusor overactivity or impaired bladder activity
  • Prolaps of pelvic organ
  • Urge incontinence
  • Neurogenic bladder
  • Bladder outlet obstruction
  • Urinary fistula, Pregnancy
  • Active urinary or vaginal enfection
  • Contraindication to anesthesia
  • \> 100ml PVR urine volume

Outcomes

Primary Outcomes

continence rates at three years after surgery

Time Frame: three years after surgery

Ultrapromesh® with its superior biomechanical characteristics and with its high success rates,low vaginal and urethral extrusion and denovo urgency rates determined in clinical studies,can be reliably and effectively used in sling surgery.

Secondary Outcomes

  • urethral erosion at three years after surgery(three years after surgery)
  • vaginal erosion at three years after surgery(three years after surgery)
  • Denovo urgency at three years after surgery(three years after surgery)
  • urine retantion at three years after surgery(three years after surgery)
  • sutur granuloma at three years after surgery(three years after surgery)

Similar Trials